These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 2179424)

  • 21. Quantification of Urease Activity.
    Richmond S; Yep A
    Methods Mol Biol; 2019; 2021():85-96. PubMed ID: 31309498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some biological features of Proteus bacilli. 1. Comparison of Proteus mirabilis strains provided from various sources.
    Kotelko K; Rozalski A; Deka M; Kaca W; Sidorczyk Z; Gromska W; Zych K
    Acta Microbiol Pol; 1983; 32(4):339-44. PubMed ID: 6202101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Pathogenic Potential of Proteus mirabilis Is Enhanced by Other Uropathogens during Polymicrobial Urinary Tract Infection.
    Armbruster CE; Smith SN; Johnson AO; DeOrnellas V; Eaton KA; Yep A; Mody L; Wu W; Mobley HLT
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold.
    Burall LS; Harro JM; Li X; Lockatell CV; Himpsl SD; Hebel JR; Johnson DE; Mobley HL
    Infect Immun; 2004 May; 72(5):2922-38. PubMed ID: 15102805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Swarming and pathogenicity of Proteus mirabilis in the urinary tract.
    Mobley HL; Belas R
    Trends Microbiol; 1995 Jul; 3(7):280-4. PubMed ID: 7551643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteus mirabilis MR/P fimbriae: molecular cloning, expression, and nucleotide sequence of the major fimbrial subunit gene.
    Bahrani FK; Mobley HL
    J Bacteriol; 1993 Jan; 175(2):457-64. PubMed ID: 8093447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of
    Armbruster CE; Mobley HLT; Pearson MM
    EcoSal Plus; 2018 Feb; 8(1):. PubMed ID: 29424333
    [No Abstract]   [Full Text] [Related]  

  • 28. A shift from acute to chronic spontaneous pyelonephritis in male MM mice associated with a change in the causal micro-organisms.
    Taylor DM
    Lab Anim; 1988 Jan; 22(1):27-34. PubMed ID: 3127633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteus mirabilis urease: transcriptional regulation by UreR.
    Nicholson EB; Concaugh EA; Foxall PA; Island MD; Mobley HL
    J Bacteriol; 1993 Jan; 175(2):465-73. PubMed ID: 7678244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection.
    Li X; Zhao H; Lockatell CV; Drachenberg CB; Johnson DE; Mobley HL
    Infect Immun; 2002 Jan; 70(1):389-94. PubMed ID: 11748205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection.
    Jones BD; Lockatell CV; Johnson DE; Warren JW; Mobley HL
    Infect Immun; 1990 Apr; 58(4):1120-3. PubMed ID: 2180821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection.
    Zunino P; Geymonat L; Allen AG; Preston A; Sosa V; Maskell DJ
    FEMS Immunol Med Microbiol; 2001 Aug; 31(2):113-20. PubMed ID: 11549418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotyping of urinary and fecal Proteus mirabilis isolates from individuals with long-term urinary catheters.
    Mathur S; Sabbuba NA; Suller MT; Stickler DJ; Feneley RC
    Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):643-4. PubMed ID: 16167137
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathogenesis of Proteus mirabilis urinary tract infection.
    Coker C; Poore CA; Li X; Mobley HL
    Microbes Infect; 2000 Oct; 2(12):1497-505. PubMed ID: 11099936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteus morgani is less frequently associated with urinary tract infections than Proteus mirabilis--an explanation.
    Senior BW
    J Med Microbiol; 1983 Aug; 16(3):317-22. PubMed ID: 6348289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection.
    Bahrani FK; Massad G; Lockatell CV; Johnson DE; Russell RG; Warren JW; Mobley HL
    Infect Immun; 1994 Aug; 62(8):3363-71. PubMed ID: 7913698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccines for Proteus mirabilis in urinary tract infection.
    Li X; Mobley HL
    Int J Antimicrob Agents; 2002 Jun; 19(6):461-5. PubMed ID: 12135833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteus mirabilis Overview.
    Mobley HLT
    Methods Mol Biol; 2019; 2021():1-4. PubMed ID: 31309490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Diabetic Patient with Prolonged Hyperammonemia Due to Urinary Tract Infection Caused by Urease-producing Bacteria.
    Inoue S; Yasuda H; Yoshida K; Mori K; Ogawa K; Yokotsuka Y; Okamoto H
    Intern Med; 2024 Jul; 63(13):1945-1949. PubMed ID: 37926530
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Manoharan A; Farrell J; Aldilla VR; Whiteley G; Kriel E; Glasbey T; Kumar N; Moore KH; Manos J; Das T
    Front Cell Infect Microbiol; 2023; 13():1216798. PubMed ID: 37965267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.